[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PH15041A - 4-hydroxyphenylalkanolamine derivatives - Google Patents

4-hydroxyphenylalkanolamine derivatives

Info

Publication number
PH15041A
PH15041A PH19910A PH19910A PH15041A PH 15041 A PH15041 A PH 15041A PH 19910 A PH19910 A PH 19910A PH 19910 A PH19910 A PH 19910A PH 15041 A PH15041 A PH 15041A
Authority
PH
Philippines
Prior art keywords
hydroxyphenylalkanolamine
derivatives
hydroxyphenylalkanolamine derivatives
Prior art date
Application number
PH19910A
Other languages
English (en)
Inventor
Richard Everett Philion
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of PH15041A publication Critical patent/PH15041A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH19910A 1976-06-25 1977-06-24 4-hydroxyphenylalkanolamine derivatives PH15041A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69985676A 1976-06-25 1976-06-25
US80337277A 1977-06-03 1977-06-03

Publications (1)

Publication Number Publication Date
PH15041A true PH15041A (en) 1982-05-20

Family

ID=27106508

Family Applications (2)

Application Number Title Priority Date Filing Date
PH19910A PH15041A (en) 1976-06-25 1977-06-24 4-hydroxyphenylalkanolamine derivatives
PH21221A PH14332A (en) 1976-06-25 1978-05-31 4-hydroxyphenylalkanolamine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH21221A PH14332A (en) 1976-06-25 1978-05-31 4-hydroxyphenylalkanolamine derivatives

Country Status (21)

Country Link
JP (1) JPS5321134A (sv)
AR (2) AR220896A1 (sv)
AT (1) AT354420B (sv)
AU (1) AU512626B2 (sv)
CA (1) CA1091245A (sv)
CH (2) CH627447A5 (sv)
DE (1) DE2728641A1 (sv)
DK (1) DK146386C (sv)
ES (1) ES460040A1 (sv)
FI (1) FI771976A (sv)
FR (1) FR2366272A1 (sv)
GB (1) GB1544872A (sv)
HK (1) HK60184A (sv)
IE (1) IE45631B1 (sv)
IL (1) IL52353A (sv)
LU (1) LU77604A1 (sv)
NL (1) NL7707128A (sv)
NO (1) NO144848C (sv)
PH (2) PH15041A (sv)
PT (1) PT66713B (sv)
SE (1) SE7707341L (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410548A (en) 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
DE3128117A1 (de) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung
FR2623804B1 (fr) * 1987-11-27 1990-03-23 Elf Aquitaine Acylation des phenols
AU620573B2 (en) * 1987-11-27 1992-02-20 Societe Nationale Elf Aquitaine Process for phenol alkylthiolation and its application to the synthesis of 4-acyl-2-alkylthiophenols
US5101065A (en) * 1991-02-04 1992-03-31 Imperial Chemical Industries Plc Acetophenone intermediates
ES2146709T3 (es) 1991-08-21 2000-08-16 Smith & Nephew Inc Sistema de control de fluidos.
AU2474399A (en) 1998-01-26 1999-08-09 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases
EP1138666B1 (en) * 2000-03-28 2004-03-03 Council of Scientific and Industrial Research A preparation method for 4-(P-methoxyphenyl)-2-amino-butane and an insecticidal composition comprising it
CA2495962A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
JP5719292B2 (ja) * 2009-05-19 2015-05-13 本州化学工業株式会社 トリスフェノール類及びそのモノエステル置換体の製造方法及び4−アシルアラルキルフェノール誘導体
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104324977A (zh) * 2014-10-22 2015-02-04 无锡市得力手机械有限公司 一种倒立式拉丝机的卸线车
HU231124B1 (hu) * 2016-02-10 2020-12-28 Egis Gyógyszergyár Zrt. Eljárás morfológiailag egységes mirabegron és mirabegron monohidroklorid előállítására
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Also Published As

Publication number Publication date
DK146386B (da) 1983-09-26
FI771976A (sv) 1977-12-26
CA1091245A (en) 1980-12-09
PT66713A (en) 1977-07-01
DK146386C (da) 1984-03-12
IL52353A (en) 1981-07-31
ATA449377A (de) 1979-06-15
JPS5321134A (en) 1978-02-27
IE45631L (en) 1977-12-25
CH630068A5 (en) 1982-05-28
AU2636877A (en) 1979-01-04
PH14332A (en) 1981-05-29
NO772245L (no) 1977-12-28
FR2366272A1 (fr) 1978-04-28
ES460040A1 (es) 1978-05-01
HK60184A (en) 1984-08-10
DK281777A (da) 1977-12-26
FR2366272B1 (sv) 1981-03-06
AT354420B (de) 1979-01-10
AR220896A1 (es) 1980-12-15
DE2728641A1 (de) 1978-01-05
CH627447A5 (en) 1982-01-15
NL7707128A (nl) 1977-12-28
NO144848C (no) 1981-11-25
LU77604A1 (sv) 1978-02-01
PT66713B (en) 1978-11-21
IL52353A0 (en) 1977-08-31
NO144848B (no) 1981-08-17
AR227126A1 (es) 1982-09-30
IE45631B1 (en) 1982-10-20
SE7707341L (sv) 1978-02-13
AU512626B2 (en) 1980-10-23
GB1544872A (en) 1979-04-25

Similar Documents

Publication Publication Date Title
PH14332A (en) 4-hydroxyphenylalkanolamine derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
AU2222977A (en) Tetrahydro-echinocandin b derivatives
HK9585A (en) Nogarol derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
PT66360B (en) Nicotinoylaminotriazine derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1549755A (en) N-4-halobutyryl derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
IL52270A0 (en) Hydrazinopyridazine derivatives
JPS52100431A (en) Anilinoacetate derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
JPS532487A (en) Quinoxalinee1*44dioxide derivatives
JPS5283495A (en) Thienothiazine derivatives
GB1544289A (en) Thiazolinotriazine derivatives
JPS52105159A (en) Estrogene derivatives
PH13411A (en) 8-adnantylaninometryl ergolene derivatives
JPS5297915A (en) Alkylaminoglucopyranoside derivatives
AU2536577A (en) 2-nitroindandione derivatives
JPS5283696A (en) Cephalospoline derivatives
GB1535080A (en) Naphthacenequinone derivatives